TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pharmore Consulting AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
3,653
|
3,448
|
2,391 |
| Financial expenses |
2
|
1
|
2 |
| Earnings before taxes |
717
|
731
|
436 |
| EBITDA |
718
|
731
|
397 |
| Total assets |
1,023
|
978
|
635 |
| Current assets |
951
|
907
|
568 |
| Current liabilities |
304
|
303
|
192 |
| Equity capital |
719
|
675
|
443 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
70.3%
|
69.0%
|
69.8% |
| Turnover per employee |
1,826
|
1,724
|
1,196 |
| Profit as a percentage of turnover |
19.6%
|
21.2%
|
18.2% |
| Return on assets (ROA) |
70.3%
|
74.8%
|
69.0% |
| Current ratio |
312.8%
|
299.3%
|
295.8% |
| Return on equity (ROE) |
99.7%
|
108.3%
|
98.4% |
| Change turnover |
142
|
887
|
368 |
| Change turnover % |
4%
|
35%
|
18% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.